Clinical Genomics Uppsala receives SweLife grant for implementation of ultrasensitive mutation detection method


Clinical Genomics Uppsala receives a grant from Swelife and Medtech4Health – Collaboration project for better health together with Rarity Bioscience, Uppsala University and Karolinska Institutet. The aim of the project is to implement the ultrasensitive mutation detection method, SuperRCA, for precision diagnostics and detection of relapse in acute myeloid leukemia and myelodysplastic syndrome.

Clinical Genomics Uppsala has a long-term collaboration with Prof. Ulf Landegren’s research group and subsequently Rarity Bioscience around the development and adaptation of the SuperRCA technology for clinical use. The role of Clinical Genomics Uppsala has been to benchmark SuperRCA against digital droplet PCR, which is already used in clinical practice, using clinical samples. 

News article from Rarity Bioscience about the SweLife grant

About Swelife
Swelife – For a competitive life science ecosystem in Sweden
Swelife is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners. Wesupport collaboration within academia, industry and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health.

About Medtech4Health
Medtech4Health strive to increase the number and quality of new innovative products and services within medtech. In collaboration with patients, healthcare, academia and business, we contribute to increasing value for people affected by disease in their everyday lives. Medtech4Health is funded by the Swedish government through the innovation authority Vinnova and by the programme’s partners.

Last modified: 2024-02-23